Corteva, Inc. (NYSE:CTVA) Receives Average Recommendation of “Moderate Buy” from Analysts

Corteva, Inc. (NYSE:CTVA) has been assigned an average recommendation of “Moderate Buy” from the twenty-three ratings firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $91.3810.

A number of equities analysts have issued reports on the company. CICC Research increased their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $101.00 price objective on shares of Corteva in a research report on Monday. Citigroup lifted their target price on Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday. Oppenheimer boosted their target price on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Finally, Mizuho raised their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th.

Corteva Stock Performance

Shares of Corteva stock opened at $76.82 on Friday. Corteva has a 12 month low of $60.53 and a 12 month high of $90.97. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $51.26 billion, a PE ratio of 50.88, a PEG ratio of 2.41 and a beta of 0.57. The stock’s fifty day simple moving average is $81.96 and its 200 day simple moving average is $79.84.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts predict that Corteva will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Institutional Investors Weigh In On Corteva

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in shares of Corteva by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the last quarter. State Street Corp increased its position in shares of Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares during the last quarter. Franklin Resources Inc. raised its holdings in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after acquiring an additional 805,873 shares in the last quarter. Harris Associates L P raised its holdings in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after acquiring an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp boosted its position in Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after purchasing an additional 562,550 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.